| HGNC Family | Non-coding RNAs |
| Name | microRNA 575 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA-575 (miR-575) emerges as an important regulator in several types of cancer by acting predominantly as an oncogenic factor. In gastric cancer, elevated miR-575 accelerates tumor development by directly targeting the tumor suppressor PTEN, which leads to increased proliferation and resistance to apoptosis, positioning miR-575 as a promoter of cancer cell survival and growth."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn estrogen receptor–positive breast cancer, miR-575 is upregulated and participates in a feedback loop with ERα, whereby its overexpression decreases tamoxifen sensitivity through the direct downregulation of CDKN1B and BRCA1. This modulation disrupts the normal control of cell cycle progression and DNA repair, contributing to therapy resistance and poorer patient outcomes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond tumor cells, miR-575 also plays a role in vascular biology. In endothelial cells from hypertensive patients, its overexpression impairs angiogenesis by inhibiting migration and proliferation and promoting apoptotic pathways through targeting Rab5B. This function links miR-575 to atherosclerotic risk by modulating early vascular remodeling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn brain malignancies, such as glioma and glioblastoma, increased levels of miR-575 have been correlated with aggressive disease phenotypes. In glioma tissues, miR-575 upregulation is associated with enhanced proliferation, migration, and invasion, and it serves as a potential prognostic biomarker for patient survival. Similar associations with overall survival have been reported in glioblastoma—suggesting that miR-575 contributes to tumorigenesis and disease progression in these central nervous system tumors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ya-Nan Wang, Fang Xu, Pei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-575 regulates development of gastric cancer by targeting PTEN."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.108716"}], "href": "https://doi.org/10.1016/j.biopha.2019.108716"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30844657"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30844657"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Shu-Shu Liu, Yun Li, Hui Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.46297"}], "href": "https://doi.org/10.7150/thno.46297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32929377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32929377"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xin Zhao, Yaping Yi, Chao Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-575 suppresses angiogenesis by targeting Rab5-MEK-ERK pathway in endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181218"}], "href": "https://doi.org/10.1042/BSR20181218"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30333257"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30333257"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Guangxin Wei, Shengjun Li, Pengcheng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered Expression of miR-575 in Glioma is Related to Tumor Cell Proliferation, Migration, and Invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromolecular Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12017-021-08679-7"}], "href": "https://doi.org/10.1007/s12017-021-08679-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34272655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34272655"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ashley Gray, Tiantian Cui, Erica Hlavin Bell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Pathol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexmp.2022.104813"}], "href": "https://doi.org/10.1016/j.yexmp.2022.104813"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35901926"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35901926"}]}]}]}
|
| Synonyms | MIRN575, HSA-MIR-575 |
| NCBI Gene ID | 693160 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR575 has 269 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 11 datasets.
Click the + buttons to view associations for MIR575 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR575 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR575 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR575 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR575 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR575 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR575 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR575 from the GeneSigDB Published Gene Signatures dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR575 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR575 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR575 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR575 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |